| 401 |
15907917 | Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology. | 2005 Jun |
1 |
| 402 |
15974920 | Analysis of genetic polymorphisms in acetylcholinesterase as reflected in different populations. | 2005 Apr |
2 |
| 403 |
16149071 | Histone acetylase inhibitor trichostatin A induces acetylcholinesterase expression and protects against organophosphate exposure. | 2005 Nov 1 |
1 |
| 404 |
16245689 | [Theoretical conformational analysis in the determination of productive conformations of substrates for acetylcholinesterase and butyrylcholinesterase]. | 2005 Sep-Oct |
2 |
| 405 |
16256966 | Interactions between the peripheral site and the acylation site in acetylcholinesterase. | 2005 Dec 15 |
2 |
| 406 |
16262697 | Biochemical characterization of human umbilical vein endothelial cell membrane bound acetylcholinesterase. | 2005 Nov |
1 |
| 407 |
16293236 | Bioscavengers for the protection of humans against organophosphate toxicity. | 2005 Dec 15 |
1 |
| 408 |
16498728 | Kinetics of hydrolysis of acetylthiocholine and acetylcholine by cholinesterases. | 2005 Dec 15 |
4 |
| 409 |
16854005 | Modeling effects of oxyanion hole on the ester hydrolysis catalyzed by human cholinesterases. | 2005 Dec 8 |
6 |
| 410 |
21783509 | Pharmacology and toxicology of cholinesterase inhibitors: uses and misuses of a common mechanism of action. | 2005 May |
1 |
| 411 |
15019964 | Long-term functional neurotoxicity of paraoxon and chlorpyrifos: behavioural and pharmacological evidence. | 2004 Mar-Apr |
1 |
| 412 |
15060281 | Acetylcholinesterase/paraoxonase genotype and expression predict anxiety scores in Health, Risk Factors, Exercise Training, and Genetics study. | 2004 Apr 13 |
1 |
| 413 |
15132713 | Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. | 2004 |
1 |
| 414 |
15134572 | Acetylcholinesterase imaging: its use in therapy evaluation and drug design. | 2004 |
1 |
| 415 |
15233279 | A simple method for the detection of abnormal brain regions in Alzheimer's disease patients using [11C]MP4A: comparison with [123I]IMP SPECT. | 2004 May |
1 |
| 416 |
15304240 | Cholinesterase inhibitors: new roles and therapeutic alternatives. | 2004 Oct |
1 |
| 417 |
15333988 | [Pre-clinical evaluation of effects of acetylcholinesterase inhibition on the cerebral cholinergic neuronal system and cognitive function: PET study in conscious monkeys]. | 2004 Sep |
1 |
| 418 |
15459952 | A paradigm for single nucleotide polymorphism analysis: the case of the acetylcholinesterase gene. | 2004 Nov |
2 |
| 419 |
15465282 | Blood-cell-specific acetylcholinesterase splice variations under changing stimuli. | 2004 Nov |
1 |
| 420 |
15544502 | An overview of the current and novel drugs for Alzheimer's disease with particular reference to anti-cholinesterase compounds. | 2004 |
3 |
| 421 |
15551380 | Acetylcholine and choline effects on erythrocyte nitrite and nitrate levels. | 2004 Nov-Dec |
1 |
| 422 |
15616167 | The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies. | 2004 Fall |
1 |
| 423 |
20641273 | 1-[11C]Methylpiperidin-4-yl propionate | 2004 |
2 |
| 424 |
20641824 | N-[11C]Methylpiperidin-4-yl acetate | 2004 |
3 |
| 425 |
20945563 | N-[18F]Fluoroethylpiperidin-4ylmethyl acetate | 2004 |
3 |
| 426 |
12507730 | Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide. | 2003 Jan |
1 |
| 427 |
12635450 | Galantamine hydrobromide: an agent for Alzheimer's disease. | 2003 Mar 1 |
1 |
| 428 |
12701885 | Enantiomer effects of huperzine A on the aryl acylamidase activity of human cholinesterases. | 2003 Feb |
2 |
| 429 |
12811800 | Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus. | 2003 Aug 11 |
1 |
| 430 |
12956931 | Apoptosis induced by beta-amyloid25-35 in acetylcholinesterase-overexpressing neuroblastoma cells. | 2003 Sep |
1 |
| 431 |
14560923 | Inhibitory effect of trans-N-p-coumaroyl tryamine from the twigs of Celtis chinensis on the acetylcholinesterase. | 2003 Sep |
1 |
| 432 |
14565292 | Non-inhibition of acetylcholinesterase by cycloSal nucleotides. | 2003 May-Aug |
1 |
| 433 |
14627729 | Studying the roles of W86, E202, and Y337 in binding of acetylcholine to acetylcholinesterase using a combined molecular dynamics and multiple docking approach. | 2003 Dec |
3 |
| 434 |
15181665 | The role of oximes in the management of organophosphorus pesticide poisoning. | 2003 |
1 |
| 435 |
15259428 | Organophosphorus ester-induced chronic neurotoxicity. | 2003 Aug |
1 |
| 436 |
11888725 | Reagent-less detection of a competitive inhibitor of immobilized acetylcholinesterase. | 2002 May |
1 |
| 437 |
11926533 | Effects of L-phenylalanine on acetylcholinesterase and Na+,K+-ATPase activities in suckling rat frontal cortex, hippocampus and hypothalamus. | 2002 Jan-Feb |
2 |
| 438 |
11929041 | The effects of some porphyrinogenic drugs on the brain cholinergic system. | 2002 Feb |
1 |
| 439 |
12105904 | Studying enzyme binding specificity in acetylcholinesterase using a combined molecular dynamics and multiple docking approach. | 2002 Jul 17 |
3 |
| 440 |
12138250 | The origin of the molecular diversity and functional anchoring of cholinesterases. | 2002 May-Jun |
1 |
| 441 |
12140604 | Galanthamine as bis-functional ligand for the acetylcholinesterase. | 2002 Jun |
1 |
| 442 |
12177686 | Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease. | 2002 Summer |
1 |
| 443 |
12183113 | Positron emission tomography: quantitative measurement of brain acetylcholinesterase activity using radiolabeled substrates. | 2002 Jul |
1 |
| 444 |
12395932 | Isolation of acetylcholinesterase from apoptotic human lung fibroblast cells by antibody affinity chromatography. | 2002 Oct |
2 |
| 445 |
12403587 | Enhanced measurement stability and selectivity for choline and acetylcholine by capillary electrophoresis with electrochemical detection at a covalently linked enzyme-modified electrode. | 2002 Oct 15 |
1 |
| 446 |
12428764 | The spectrum of congenital myasthenic syndromes. | 2002 Oct-Dec |
2 |
| 447 |
12436423 | Cholinergic interneuron characteristics and nicotinic properties in the striatum. | 2002 Dec |
1 |
| 448 |
12456061 | Development of human antibody fragments directed towards synaptic acetylcholinesterase using a semi-synthetic phage display library. | 2002 |
1 |
| 449 |
12481195 | Nicotinic cholinergic modulation: galantamine as a prototype. | 2002 Winter |
2 |
| 450 |
12498995 | Reduced acetylcholinesterase activity in erythrocyte membranes from patients with phenylketonuria. | 2002 Nov |
1 |